helpful in designing more effective immune system-based therapies.
Perhaps one obstacle in studying leukocyte trafficking in gliomas is the difficulty associated with quantifying inflammatory cells in tumor samples. Immunohistochemical methods are commonly used to characterize tumor-associated inflammatory cells. The application of this technique, however, is limited by its inability to distinguish cells bearing similar antigens and by its inaccuracy in measuring positive-staining cells. Widely used in the field of immunology, FACS is an alternative method to separate and quantify individual cell types in a heterogeneous cell population. We recently reported the use of this technique in characterizing the extent of tumor-infiltrating inflammatory cells in experimental gliomas. 2 The ability to stain tissue simultaneously with multiple antibodies permits identification of cells carrying similar surface antigens (such as microglia and macrophages) as well as quantification of infiltrating inflammatory cells in glioma models.
To study the role of dexamethasone in the CNS reaction to brain tumors, we used FACS to characterize the immune response in an immunogenic rat glioma model. We noted that, even at low doses, dexamethasone inhibited lymphocyte infiltration into rat C6 tumors. Although the number of tumor-associated microglia and macrophages also decreased, higher doses of dexamethasone were needed to elicit this response.
Materials and Methods

Cell Culture and Antibodies
Rat C6 cells were propagated in DMEM supplemented with 10% FBS, penicillin (100 U/ml), streptomycin (100 mg/ml), and HEPES (0.01 mol/ml). All antibodies-FITC-conjugated anti-rat CD45 (clone OX-1), PE-conjugated anti-rat CD11b/c (clone OX-42), PEconjugated anti-rat CD8a (clone OX8), and FITC-conjugated antiKi67 (clone B56)-as well as isotype controls were used at a dilution of 1:100.
Tumor Implantation
All animals were housed and handled in accordance with the University of Wisconsin Research Animal Resources Center guidelines. Cells were harvested by trypsinization, counted, and resuspended in 1.2% methylcellulose. Female Wistar rats weighing 100 to 200 g each were anesthetized by intraperitoneal administration of ketamine (50-90 g/kg) and xylazine (10 mg/kg), then immobilized in a stereotactic head frame. Through a small burr hole, 5 l of methylcellulose containing 10 6 tumor cells was injected into the brain at the coronal suture, 4 mm lateral to the midline and 5 mm deep into the left frontal lobe, by using a Hamilton syringe. Shamoperated animals received injections of an equal volume of methylcellulose without tumor cells.
Dexamethasone Treatment
Four days after tumor implantation, the animals were given daily intraperitoneal injections of dexamethasone (0.1 or 1 mg/kg) or PBS (control animals) for a total duration of 7 days until their brains were harvested for flow cytometry.
Tissue Preparation
Approximately 11 days after tumor implantation, the animals were anesthetized and perfused with 300 ml ice-cold PBS containing 1000 U/L heparin. Each rat brain was removed and the tumor, tumor periphery, and contralateral tumor-free hemisphere were isolated. Because of technical inaccuracies encountered during dissection of small tumors, and because of potential invasion into the contralateral hemisphere by larger tumors, only tumors localized to one hemisphere and measuring 3 to 6 mm in diameter were used for the analysis.
Approximately 5-mm 3 portions of each tissue sample were minced and triturated on ice in DMEM containing 10% FBS. Only one sample from each location was processed from each animal. The tissue suspension was forced through a sterile 70-m filter and centrifuged at 300 G for 5 minutes.
Flow Cytometry
Flow cytometry was used to assess inflammatory cell infiltration in tumors, tumor periphery, and contralateral hemisphere. Following tissue preparation, the cells were resuspended in cold PBS, incubated with the appropriate antibodies for 1 hour at 4˚C, washed once in PBS, and resuspended in 250 l of PBS containing 1 g/ml propidium iodide. Approximately 10 4 live gated events were assessed on a flow cytometer by using a 15-mW 488-nm-wavelength air-cooled argon ion laser and a No. 635 red diode. Propidium iodide-positive cells and debris, which accounted for 40 to 50% of total detected particles, were excluded from each analysis.
Proliferative Index
Following tissue preparation and resuspension in ice-cold PBS, the cells were incubated with anti-rat CD11b/c-PE for 1 hour at 4˚C. Samples were then washed with PBS and resuspended in icecold 4% paraformaldehyde. After two more washes with PBS, cells were resuspended in PBS containing 0.2% Tween-20 and incubated at room temperature for 10 minutes. Cells were incubated with anti-Ki67 antibody for 1 hour at 4˚C, washed twice with PBS/ Tween-20, resuspended in PBS, and analyzed using flow cytometry. Forward and side scatter determinations were used to exclude debris from analysis.
Statistical Analysis
Student's t-test was performed using commercially available statistical computer software to compare differences in the magnitude of cell infiltration among treatment groups. Differences were considered to be significant at a probability level less than 0.05. Data are expressed as the means Ϯ SD.
Sources of Supplies and Equipment
Life Technologies, Inc. (Gaithersburg, MD), provided the DMEM, streptomycin, and HEPES. BioWhittaker (Walkersville, MD) produced the FBS. All antibodies-FITC-conjugated anti-rat CD45 (clone OX-1), PE-conjugated anti-rat CD11b/c (clone OX-42), PE-conjugated anti-rat CD8a (clone OX8), and FITC-conjugated anti-Ki67 (clone B56)-as well as the isotype controls were purchased from Pharmingen (San Diego, CA). The Hamilton syringe was obtained from Fisher Scientific (Tustin, CA) and the 70-m filter through which the tissue suspension was forced from Fisher Scientific (Pittsburgh, PA). Sigma Chemical Co. (St. Louis, MO) produced the propidium iodide. The FACSCaliber Benchtop Flow Cytometer was acquired from BDIS (San Jose, CA) and the statistical software from GraphPad Software (San Diego, CA).
Results
Characterization of Glioma-Infiltrating Cells
The C6 glioma model was selected for these studies because this allogeneic glioma model has been shown to be highly immunogenic. 3 Moreover, using FACS, we recently demonstrated that intracranial C6 tumors contain a significant amount of infiltrating cells composed of microglia, macrophages, and lymphocytes. 2 This glioma model, therefore, allowed us to study not only trafficking of lymphocytes, but also of other inflammatory cells. Furthermore, because the C6 cells were negative for CD11b/c and CD45 antigens in vitro, any ex vivo staining of CNS tissue most likely represented infiltrating inflammatory cells.
To differentiate between CNS microglia and macrophages, which express similar surface antigens, tissue samples were simultaneously stained with both CD11b/c and CD45 antibodies. The CD11b/c is a marker for both macrophages and microglia, 20 whereas CD45, a common leukocyte antigen, 23 is also expressed on lymphocytes. As suggested by Sedgwick and coworkers, 22 the extent of CD45 staining of CD11b/c-positive cells can be used to distinguish microglia from macrophages in the CNS. Hence, microglia were identified as CD45-slightly positive, CD11b/c-highly positive cells, and macrophages as CD45-highly positive and CD11b/c-highly positive cells (Fig. 1) .
Analysis of C6 tumors showed that microglia and lymphocytes accounted for 23 Ϯ 3% and 33 Ϯ 5% of viable cells, respectively (Fig. 2) . Macrophages, on the other hand, comprised only 9 Ϯ 1% of these cells. Interestingly, there were as many microglia and macrophages in the tumor periphery tissue, which grossly appeared to be free of tumor, as there were in the tumors themselves. This was in contrast to lymphocytes and T cells, which were more abundant in tumors than in the tumor periphery. These findings were consistent with those in our previous report. 2 
Effect of Dexamethasone on Glioma Inflammatory Reaction
To examine the effect of steroid medications on inflammatory cell infiltration in tumors, the animals were injected with two different doses of dexamethasone shortly after tumor implantation. The higher dose of dexamethasone (1 mg/kg/day) was selected because it has been shown to be effective in reducing cerebral edema in similar animal models. 25 Although there was no significant change in tumor size, dexamethasone significantly inhibited the frequency of positive-staining cells in these tumor samples (Fig. 2) . Whereas microglia infiltration was inhibited by 43% and 57%, respectively, at low and high doses of dexamethasone, lymphocyte infiltration was inhibited by 52% and 86%, respectively. Similarly, T-cell infiltration was inhibited and was completely abolished by treatment with 1 mg/kg/day of dexamethasone (Fig. 2D) . Because the mean fluorescence of each cell type did not change in the treated animals, the observed decreases in the frequency of microglia and lymphocytes were most likely due to decreases in their numbers and not to nonspecific downregulation of their receptors in response to dexamethasone. In contrast to microglia, macrophages were more resistant to steroid agents, and their infiltration decreased only in tissue in the tumor periphery (Fig. 2B) .
Effect of Dexamethasone on Proliferation of TumorAssociated Macrophages
To test whether the observed decrease in microglia frequency in dexamethasone-treated animals was due to a decline in their migration or inhibition of their proliferation, FACS was used to measure the proliferative index of CD11b/c-positive cells (microglia and macrophages) and CD11b/c-negative cells (tumor cells and lymphocytes) by using Ki67 labeling (Fig. 3) . Interestingly, in untreated animals as many as 45 Ϯ 5% of CD11b/c-positive cells were found to be Ki67 positive (Fig. 4) . When animals were treated with dexamethasone, microglial cell proliferation was inhibited by as much as 64% (p = 0.002), suggesting that the observed decrease in their accrual in tumors was due in part to the antiproliferative effect of dexamethasone on these cells. 10, 24 In contrast to CD11b/ c-positive cells, high doses of dexamethasone had no growth-inhibitory effects on tumor cells (Fig. 4 ; p = 0.34).
Discussion
In the present study, flow cytometry was used to evaluate the effect of dexamethasone on the inflammatory response of the CNS in an immunogenic rat glioma model. Dexamethasone significantly inhibited infiltration of both lymphocytes and microglia, and, at higher doses, completely abolished lymphocyte invasion of these tumors. Despite the widespread use of steroid medications in neurooncology, to our knowledge this is the first quantitative report to address the effect of dexamethasone on the trafficking of inflammatory cells in gliomas. Having direct clinical relevance, these observations also highlight the investigational value of FACS to the field of neurooncology.
Application of Flow Cytometry to Glioma Immunology Research
A number of studies have documented the presence of inflammatory cells in brain tumors (for a review see de Micco 9 ). Despite these observations, the exact role of these cells in glioma biology remains unclear. Although some investigators have proposed that lymphocytes act as antineoplastic cells (by showing a direct correlation between the extent of their infiltration and the prolonged survival of patients with gliomas), 4, 17 others have failed to substantiate this observation. 6 One of the explanations for these conflicting reports may be related to the method used in measuring the degree of immune response in glioma samples. Because of the variation in the distribution pattern of inflammatory cells within tumors, and because of the heterogeneous structure of glial cells, quantification of immune cells using histochemical techniques may be imprecise and biased by the tissue site examined. By analyzing a tumor homogenate, FACS can separate specific cell types from a heterogeneous cell population and provide an overall estimation of the number of inflammatory cells in tumor samples. Although variability in tissue yield and possible downregulation of surface receptors during tissue preparation can affect the accuracy of measurements of each cell type, this technique is nevertheless valuable in comparing differences among experimental groups.
Flow cytometry also permits the detection and study of inflammatory cells not previously discernible when using histochemical methods. One such example is the study of microglia, which express surface antigens similar to those of macrophages. The differential expression of CD45, however, has been reported by Sedgwick and coworkers 22 to be a useful method to distinguish microglia from macrophages in the CNS. We recently applied this technique to characterize and study tumor-associated macrophages in a rat glioma model. 2 In contrast to macrophages, we noted a marked response of microglia with a wide distribution pattern involving the intracranial tumor, tumor periphery, and contralateral hemisphere. In view of the fact that microglia have been reported to secrete a variety of cytokines, we inferred from these observations that tumor-associated microglia play a role in glioma biology. Although these cells may have an antineoplastic function, secretion of IL-10 by microglia (an immunosuppressive cytokine with glial motility functions) or growth factors (such as basic fibroblast growth factor and insulin-like growth factor-1) can potentially contribute to glioma progression. 11, 18, 26, 27 Flow cytometry, we believe, is a valuable tool for better characterization of the function of microglia in brain tumors.
In the present study, FACS also allowed us to measure proliferation of both CD11b 1 this observation offers another explanation for accumulation of microglia and macrophages in experimental gliomas. Perhaps in addition to secretion of chemoattractants, local release of growth factors by glioma cells may also contribute to the accrual of macrophages in these tumors. Furthermore, because most CD11b/c-positive cells expressed low levels of CD45, this finding also suggests that local CNS microglia, and not blood-borne monocytes, accounted for most of the glioma-associated macrophages. If migration of blood-borne monocytes were the only source of glioma macrophages, then one would have expected most CD11b/c-expressing cells to be quiescent and to express high levels of CD45 antigen.
Effect of Dexamethasone on Tumor-Associated Macrophages
More prevalent in C6 tumors, microglia were found to be more prone to dexamethasone inhibition than macrophages. At the doses examined, dexamethasone inhibited infiltration of microglia without influencing macrophage trafficking. To explain the observed decrease in microglia infiltration, the proliferative index of CD11b/c-positive cells (mostly microglia) was compared with that of CD11b/c-negative cells (mostly tumor cells). Although dexamethasone did not affect the propagation of neoplastic cells, it significantly inhibited microglia proliferation. This observation is consistent with other reports demonstrating the inhibition of microglia growth in vitro by dexamethasone. 10 Although dexamethasone has been recently shown to induce apoptosis in monocytes, it is not clear whether programmed cell death also played a role in the observed reduction in tumor-associated microglia. 21 
Effect of Dexamethasone on Lymphocyte Infiltration
The antiinflammatory functions of glucocorticoid agents have been well studied. Steroid medications can inhibit IL-2 production by T cells, suppress natural killer cell function, and induce programmed cell death in immature and activated lymphocytes. 5, 14 Considering these immunosuppressive functions, it was not surprising to see a decrease in lymphocyte infiltration into C6 tumors following dexamethasone administration. The observed complete obliteration of tumor-associated lymphocytes, however, was unexpected and underscores the local immunosuppressive potential of dexamethasone in patients with gliomas.
Clinical Relevance of Findings
Augmentation of the host immune reaction against tumors is a promising treatment strategy that is currently being evaluated for a number of cancers including malignant gliomas. With potential application to humans, generation of tumor-specific cytotoxic lymphocytes accomplished using vaccine strategies is being actively investigated in animal glioma models. Because these experimental strategies rely heavily on cytotoxic lymphocyte migration to tumor sites, any immunosuppressive factor can significantly influence their clinical efficacy. Although the C6 glioma model does not truly represent a primary human brain tumor, our observations may have implications in the development of novel glioma therapies. Because dexamethasone was capable of inhibiting the host immune response to C6 gliomas even at low doses, and because most glioma patients receive dexamethasone for treatment of cerebral edema, we propose that any experimental immune-based therapy should also be tested in dexamethasone-treated animals before its clinical application is considered.
Our observations also point out another possible mechanism by which steroid medications can reduce tumorinduced cerebral edema. By inhibiting the trafficking of inflammatory cells into brain tumors, dexamethasone can also prevent the release of proinflammatory cytokines that can potentially exacerbate brain edema. For example, dexamethasone has been reported to inhibit the release of nitric oxide and a variety of proinflammatory cytokines such as tumor necrosis factor-␣ and IL-6␣ by microglia. 7, 13, 15 By reducing microglia trafficking and proliferation and cytokine release, dexamethasone can theoretically diminish the extent of cerebral edema in these tumors. Whether inflammatory cells are a major contributor to the development of cerebral edema in gliomas, however, is not clear and should be examined further.
Conclusions
We have demonstrated that, even at low concentrations, dexamethasone can inhibit the inflammatory response in a glioma model and significantly inhibit the proliferation of tumor-associated macrophages. It would be interesting to examine whether these inhibitory effects are reversible after dexamethasone withdrawal.
